BioPharma Resources

Therapeutic area

Dermatology

Acne, rosacea, actinic keratosis and other skin conditions. Drugs are placed in areas by keyword matches on their FDA pharmacologic class and approved use, and trials by their listed conditions, so a few land in the wrong area.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.govMethods & limitations

Approvals since 2023

8

Originals, plus breakthrough or accelerated new uses

Recruiting Phase 2

14

Industry-sponsored

Recruiting Phase 3

13

Industry-sponsored

Recruiting Phase 4 (post-approval)

3

Industry-sponsored

Recent approvals

All
  • Lisraya (Brepocitinib Tosylate) · Priovant Therap NovelPriority reviewOrphanAug 27, 2026

    To treat dermatomyositis in adults

  • Differin Epiduo Acne Gel (Adapalene and Benzoyl Peroxide) (Adapalene, Benzoyl Peroxide, Adapalene, Benzoyl Peroxide) · Galderma Labs Lp May 22, 2026
  • Adquey (Difamilast) · Acrotech Biopharma NovelFeb 12, 2026

    To treat mild to moderate atopic dermatitis

  • Anzupgo (Delgocitinib) · Leo Pharma As NovelJul 23, 2025

    To treat moderate-to-severe chronic hand eczema when topical corticosteroids are not advisable or produce an inadequate response

  • Ebglyss (Lebrikizumab-Lbkz) · Eli Lilly and CO NovelSep 13, 2024

    To treat moderate-to-severe atopic dermatitis

  • Sofdra (Sofpironium Bromide) · Botanix Sb NovelJun 18, 2024

    To treat primary axillary hyperhidrosis

  • Zevtera (Ceftobiprole Medocaril Sodium) · Istx NovelPriority reviewApr 3, 2024

    To treat certain bloodstream infections, bacterial skin and associated tissue infections, and community-acquired bacterial pneumonia

  • Filsuvez (Birch Triterpenes) · Chiesi NovelPriority reviewOrphanDec 18, 2023

    To treat wounds associated with dystrophic and junctional epidermolysis bullosa

Recruiting trials by phase

Industry-sponsored drug and biologic trials.

Most approvals since then, by company

Drugs in development

Investigational drugs in Phase 2 and 3 trials for conditions in this area, most trials first.

All
  • RilvegostomigAZD2936Phase 325 trials

    AstraZeneca · Biliary Tract Cancer, Gastric Cancer, Non-small Cell Lung Cancer

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • AmlitelimabSAR445229Phase 39 trials

    Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • SHR-1819Phase 38 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • barzolvolimabCDX-0159Phase 37 trials

    Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • SHR-1905Phase 36 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • VC005Phase 35 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis

Largest recruiting Phase 3 trials

All

More: Dermatology news · literature

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.